Association between FTO gene polymorphisms and breast cancer: the role of estrogen. Issue 2 (3rd March 2020)

• Record Type: Journal Article
• Authors: Gholamalizadeh, Maryam; Jarrahi, Alireza Mosavi; Akbari, Mohammad Esmail; Bourbour, Fatemeh; Mokhtari, Zohreh; Salahshoornezhad, Sara; Doaei, Saeid
• Is Part Of: Expert review of endocrinology & metabolism. Volume 15:Issue 2(2020)
• Page Start: 115
• Page End: 121
• Publication Date: 2020-03-03
• Subjects: Breast cancer -- FTO gene -- genotype -- polymorphism; Endocrinology -- Periodicals; Metabolism -- Periodicals; 616.4
• DOI: 10.1080/17446651.2020.1730176
• Languages: English
• ISSNs: 1744-6651

Abstract

ABSTRACT: Introduction : The fat mass and obesity-associated ( FTO ) gene may be associated with breast cancer risk. This study aimed to systematically investigate the association between FTO gene polymorphisms and breast cancer and the possible role of estrogen in this association. Areas covered : We performed an extensive search of electronic databases such as PubMed, Science Direct, Scopus, and Cochran for published original studies on the association of FTO gene polymorphisms with breast cancer risk. Keywords such as breast cancer and/or FTO gene and/or polymorphism were used in order to identify the related articles. We excluded studies unrelated to the FTO genotype and the outcome of breast cancer. Expert opinion : FTO gene may have a significant association with the risk of breast cancer. The association between FTO gene polymorphisms and breast cancer was influenced by the status of estrogen receptors. Estrogen may promote breast cancer cell proliferation through up-regulation of FTO gene expression and activation of the PI3 K/Akt signaling pathway in estrogen receptor positive patients. Further studies are warranted to identify the underlying mechanisms and signaling pathways involved in the interactions between FTO gene, estrogen, and the risk of breast cancer.